Clinical Trial Update: Geographic Atrophy and Intravitreal Ranibizumab Injections

View source ↗

Summary

This entry reports a clinical trial update evaluating intravitreal ranibizumab injections for geographic atrophy in age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Age-related Macular Degeneration, Geographic Atrophy | Status: UNKNOWN